Nalaganje...
Disabling mitochondrial reprogramming in cancer
Recent studies have demonstrated that tumor cells exposed to molecular therapy with PI3K antagonists redistribute their mitochondria to the peripheral cytoskeleton, fueling membrane dynamics, turnover of focal adhesion complexes and increased tumor cell motility and invasion. Although this process p...
Shranjeno v:
| izdano v: | Pharmacol Res |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4684442/ https://ncbi.nlm.nih.gov/pubmed/26365877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2015.08.022 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|